Free Trial

12 Cannabis Stocks to Buy Now - 5 of 12

 
 

Organigram (TSE:OGI)

MarketBeat Followers
1,205
Market Cap
C$182.84 million
Consensus Rating
Buy
Rating Score
3.0
Ratings Breakdown
1 Buy Ratings, 0 Hold Ratings, 0 Sell Ratings.
Consensus Price Target
C$3.67 (147.7% Upside)

About Organigram

Organigram logoOrganigram Inc is a Canadian licensed producer of cannabis products. Organigram focuses on producing exceptional, indoor-grown cannabis for patients and adult recreational consumers, as well as developing global business partnerships.
 

Recent Analyst Ratings

DateBrokerageActionRatingPrice TargetDetails
12/17/2024ATB CapitalLower Price TargetC$5.25 ➝ C$3.50
12/9/2024Canaccord Genuity GroupLower Price TargetSpeculative BuyC$3.60 ➝ C$3.15
8/14/2024Canaccord Genuity GroupBoost Price TargetSpeculative BuyC$3.25 ➝ C$3.60
5/17/2024Jefferies Financial GroupLower Price TargetC$4.40 ➝ C$4.35
5/15/2024Canaccord Genuity GroupLower Price TargetSpeculative BuyC$3.75 ➝ C$3.25
4/3/2024ATB CapitalSet Price TargetOutperformC$5.25
2/27/2024Jefferies Financial GroupLower Price TargetBuyC$4.95 ➝ C$4.40
2/14/2024Alliance Global PartnersBoost Price TargetNeutralC$2.00 ➝ C$2.70
12/20/2023ATB CapitalBoost Price TargetOutperformC$5.50 ➝ C$6.50
12/20/2023Alliance Global PartnersLower Price TargetC$2.25 ➝ C$2.00